Headache after frequent use of serotonin agonists zolmitriptan and naratriptan

被引：86

作者：

Limmroth, V ^{[1
]}

Kazarawa, Z ^{[1
]}

Fritsche, G ^{[1
]}

Diener, HC ^{[1
]}

机构：

[1] Univ Essen Gesamthsch, Sch Med, Dept Neurol, D-45122 Essen, Germany

来源：

LANCET | 1999年 / 353卷 / 9150期

关键词：

D O I：

10.1016/S0140-6736(05)74950-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：378 / 378

页数：1

共 4 条

[1] Inappropriate use of sumatriptan: population based register and interview study [J].

Gaist, D ;

Tsiropoulos, I ;

Sindrup, SH ;

Hallas, J ;

Ramussen, BK ;

Kragstrup, J ;

Gram, LF .

BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7141) :1352-1353

[2] Naratriptan [J].

Gunasekara N.S. ;

Wiseman L.R. .

CNS Drugs, 1997, 8 (5) :402-408

[3] SUMATRIPTAN [J].

KAUBE, H ;

MAY, A ;

DIENER, HC ;

PFAFFENRATH, V .

BRITISH MEDICAL JOURNAL, 1994, 308 (6943) :1573-1574

[4] Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan) [J].

Martin, GR ;

Robertson, AD ;

MacLennan, SJ ;

Prentice, DJ ;

Barrett, VJ ;

Buckingham, J ;

Honey, AC ;

Giles, H ;

Moncada, S .

BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (02) :157-164

← 1 →